» Articles » PMID: 30825060

About the Controversies of the Cardioprotective Effect of N-3 Polyunsaturated Fatty Acids (PUFAs) Between Animal Studies and Clinical Meta-analyses: a Review with Several Strategies to Enhance the Beneficial Effects of N-3 PUFAs

Overview
Specialties Biochemistry
Physiology
Date 2019 Mar 3
PMID 30825060
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Several meta-analyses describing the effect of n-3 polyunsaturated fatty acids on the survival rate of the victims of an acute coronary event do not clearly support a beneficial impact of these fatty acids. Yet, animal studies consistently show n-3 PUFA-induced protection against ischemia-reperfusion-induced myocardial injuries. The impact on reperfusion arrhythmias of these PUFAs is more controversial. The literature shows the anti-arrhythmic properties of circulating n-3 PUFAs. However, when these fatty acids are incorporated in the cardiac membrane, they protect the myocardial tissue vis a vis cellular damage but they can be either pro- or anti-arrhythmic during reperfusion, depending on the severity of tissue injuries. The latter elements can explain the lack of beneficial effect observed in the meta-analyses, but a proper use of n-3 PUFAs may provide advantages in terms of survival rate. This review discusses the different results obtained in humans and animals and presents several strategies to enhance the beneficial effects of n-3 PUFAs.

Citing Articles

Mechanisms Underlying Antiarrhythmic Properties of Cardioprotective Agents Impacting Inflammation and Oxidative Stress.

Andelova K, Szeiffova Bacova B, Sykora M, Hlivak P, Barancik M, Tribulova N Int J Mol Sci. 2022; 23(3).

PMID: 35163340 PMC: 8835881. DOI: 10.3390/ijms23031416.

References
1.
Clifton P, Keogh J . A systematic review of the effect of dietary saturated and polyunsaturated fat on heart disease. Nutr Metab Cardiovasc Dis. 2017; 27(12):1060-1080. DOI: 10.1016/j.numecd.2017.10.010. View

2.
Konig A, Bouzan C, Cohen J, Connor W, Kris-Etherton P, Gray G . A quantitative analysis of fish consumption and coronary heart disease mortality. Am J Prev Med. 2005; 29(4):335-46. DOI: 10.1016/j.amepre.2005.07.001. View

3.
Wen Y, Dai J, Gao Q . Effects of Omega-3 fatty acid on major cardiovascular events and mortality in patients with coronary heart disease: a meta-analysis of randomized controlled trials. Nutr Metab Cardiovasc Dis. 2014; 24(5):470-5. DOI: 10.1016/j.numecd.2013.12.004. View

4.
Langlois P, Hardy G, Manzanares W . Omega-3 polyunsaturated fatty acids in cardiac surgery patients: An updated systematic review and meta-analysis. Clin Nutr. 2016; 36(3):737-746. DOI: 10.1016/j.clnu.2016.05.013. View

5.
Lorente-Cebrian S, Costa A, Navas-Carretero S, Zabala M, Martinez J, Moreno-Aliaga M . Role of omega-3 fatty acids in obesity, metabolic syndrome, and cardiovascular diseases: a review of the evidence. J Physiol Biochem. 2013; 69(3):633-51. DOI: 10.1007/s13105-013-0265-4. View